An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants
Description
mRNA-based vaccines and therapeutic agents hold great promise in prevention and treatment of human diseases, yet high percentage of systemic adverse effect in clinic remains a big safety concern. One major potential cause is a high level of leakage